US Capitol Capsule: House user fee bill more costly to US than Senate's, CBO reports
This article was originally published in Scrip
Executive Summary
While the US FDA user fee legislation adopted by the Senate on 24 May could potentially save the US millions of dollars in direct spending costs and reduce the deficit, the House version of the bill would actually increase spending and put the nation further in debt, according to a new analysis.